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Twitcher miceKrabbe disease is an inherited lysosomal disorder in which galactosylsphingosine (psychosine) accumulates
mainly in the central nervous system. To gain insight into the possible mechanism(s) that may be
participating in the inhibition of the postnatal somatic growth described in the animal model of this disease
(twitcher mouse, twi), we studied their femora. This study reports that twi femora are smaller than of those
of wild type (wt), and present with abnormality of marrow cellularity, bone deposition (osteoblastic
function), and osteoclastic activity. Furthermore, lipidomic analysis indicates altered sphingolipid home-
ostasis, but without signiﬁcant changes in the levels of sphingolipid-derived intermediates of cell death
(ceramide) or the levels of the osteoclast–osteoblast coupling factor (sphingosine-1-phosphate). However,
there was signiﬁcant accumulation of psychosine in the femora of adult twi animals as compared to wt,
without induction of tumor necrosis factor-alpha or interleukin-6. Analysis of insulin-like growth factor-1
(IGF-1) plasma levels, a liver secreted hormone known to play a role in bone growth, indicated a drastic
reduction in twi animals when compared to wt. To identify the cause of the decrease, we examined the IGF-1
mRNA expression and protein levels in the liver. The results indicated a signiﬁcant reduction of IGF-1 mRNA
as well as protein levels in the liver from twi as compared to wt littermates. Our data suggest that a
combination of endogenous (psychosine) and endocrine (IGF-1) factors play a role in the inhibition of
postnatal bone growth in twi mice; and further suggest that derangements of liver function may be
contributing, at least in part, to this alteration.e; IGF-1, insulin-like growth
rogenase; qPCR, quantitative
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The infantile form of Krabbe disease (Globoid cell leukodystrophy)
is the most common, severe, rapidly progressing, neurodegenerative
and invariably fatal, inherited metabolic disease produced by
mutations on the β-galactosylcerebrosidase gene, which expresses a
lysosomal enzyme that participates in the degradation of several
glycosphingolipids [1,2]. As a consequence, galactosylsphingosine
(psychosine, also a substrate of the enzyme [3]) accumulates in thenervous system [3] and peripheral organs [4]. The availability of a
mutant mouse (twitcher mouse; twi), that is a morphologically,
genetically and enzymatically authentic murine model of the human
disease [5], has been a valuable tool to advance our understanding of
the development/progression of the disease in the central nervous
system. In the nervous system, accumulation of psychosine exerts a
cytotoxic effect especially on myelin-producing cells (oligodendro-
cytes) [6], with further induction of myelin degeneration, astrocytic
gliosis, axonal loss and presence of multinucleate giant (globoid) cells
[1]. Psychosine-induced local inﬂammatory response in the nervous
system (induction of proinﬂammatory cytokines and intermediates)
[7–10] plays a role in the early apoptotic loss of oligodendrocytes
[11,12] observed in Krabbe patients [13,14] and twitcher mice [15]
brains.
Twitcher mouse develops clinical signs by day 20th, characterized
by stunted growth, twitching and hind leg weakness; and the disease
progresses to a near-terminal stage by days 40–45 [1]. The twitching
sign is associated with the loss of oligodendrocytes [16–18]; however,
the cause of decreased somatic growth is unclear. Multiple etiologies
could underlie this growth defect; but alteration of hypothalamic–
hypophysial axis function may play a causative role. Growth hormone
Fig. 1. Growth curves and differences in femora size and weight between wild type and
twitcher mice. Signiﬁcant differences between mice body weight (A), and length and
weight (33 days; B) between femora from wild type and litters mate twitcher mice is
evident inadult animals.Graph represents theaverage±SD forn=6–7animals per group.
***: Asterisks denote signiﬁcant statistical differences from wild type littermates
(pb0.0001).WT: wild type mice; TW: Twitcher mice.
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been recognized as one of the principal factors that control postnatal
growth [19]. GH acts as a promoter of skeletal long bone growth and
development as well as chondrocyte maturation [20,21], by receptor
mediated induction of the transcription of genes whose expressed
proteins are important inmediating its diverse effects on body growth
andmetabolism [22]. GH also stimulates the expression of hepatic and
extrahepatic insulin-like growth factor-1 (IGF-1), that plays an
essential GH-mediated anabolic role on skeletal and non skeletal
tissues [23–28].
We have previously reported that psychosine accumulation
mediates the induction of cytokines in twi liver, thus compromising
some of its functions [29]. In the present report, we studied the
presence of endogenous (psychosine; Sph-1P) and humoral (IGF-1)
factors that may be responsible for the stunted growth of femora of
twi mice, to help identify possible mechanisms that may be playing a
role in the postnatal somatic growth retardation of twi mouse. Our
data indicate that: i) psychosine accumulates in femora of twimice; ii)
osteoclast function of twi femora (bone resorption) is enhanced; iii)
tartrate-resistant acid phosphatase (TRAP) activity is increased in the
growth plate; iv) twimouse femora present alteration of sphingolipid
homeostasis, without signs of change in Sph-1P or a signiﬁcant
decrease in sphingomyelin or an increase in ceramide pool; v) liver
secreted IGF-1 level is drastically reduced in twimice plasma, and vi)
IGF-1 transcripts and protein levels are signiﬁcantly down regulated
in twi liver. This study reports for the ﬁrst time evidence that
psychosine, acting either endogenously in the bone (local accumula-
tion) or in conjunction with a disrupted endocrinal signal (IGF-1), are
potential factors that mediate the alteration in bone growth, and
hence the somatic growth of twi mice.
2. Materials and methods
2.1. Animal model
All animal work for this study was performed under a protocol
approved by the Institutional Animal Care and Use Committee. Twitcher
heterozygote breeding pairs (C57BL/6 J twi+/−) were purchased from
Jackson Laboratory (Bar Harbor, ME, USA) and twi(−/−) (twi) and age-
matched littermates wild typewt(+/+) (wt) were used for this study at
postnatal days 33–34. Wt and twi animals were sacriﬁced with an
overdose of anesthetic and tissues were removed, frozen in liquid
nitrogen and stored at−70 °C.
2.2. Femora analysis of psychosine and sphingolipid levels by HPLC-mass
spectrometry
For lipidomic analysis, bones (left and right femur) were defrosted
in ice-cold phosphate buffered saline and the muscle tissue removed
manually. Individual bones were weighed, enveloped in aluminum
foil, frozen in liquid nitrogen and crushed in a mortar. Quantitative
high pressure liquid chromatography–tandem mass spectrometry
analysis of psychosine and bioactive sphingolipids were performed on
organics solvent extracts derived from wt and twi crushed bones, at
the University Lipidomics Core facility [30].
2.3. Calcein bone labeling
To deﬁne abnormal bone growth in the twi mouse, a modiﬁed
histomorphometric analysis was performed using double labeling
with calcein as a marker [31]. Adult mice were given two
intraperitoneal injections of calcein 5 days apart (postnatal days 26
and 31). Calcein was prepared in a 2% solution of sodium bicarbonate,
and injected at a dose of 20 mg/kg of body weight. Animals were
killed 2 days after the last injection (post natal day 33). Femora were
isolated and calcein was assessed in undecalciﬁed bones embedded inmethylmethacrylate. Sections 4–6 µm thick (Leica RM 2155 rotary
microtome; Leica Microsystems, Ontario, Canada) were examined
under a ﬂuorescence microscope (Olympus BX-60; excitation at
485 nm and emission at 510 nm), and the acquired images were
rendered using Adobe Photoshop 7.0.
2.4. Histology and tartrate-resistant acid phosphatase (TRAP) staining
analysis
Wild-type and twitcher mice bone specimens were ﬁxed in 4%
paraformaldehyde and dehydrated with serial changes in 70–100%
ethanol. The specimens were embedded in methylmethacrylate and
serial 4–6 μm sections were stained by Goldner's trichrome method
for light microscopy analysis [32] or stained for TRAP activity using a
histochemical kit (Sigma-Aldrich) as described elsewhere [33].
2.5. Plasma and liver analysis of insulin-like growth factor-1
Blood from wt and twi mice was collected in EDTA-K containing
vaccutainer tubes (BD Biosciences, Franklin Lakes, NJ), and the plasma
was separated by centrifugation at 900×g for 10 min (Allegra X-15R
centrifuge, Beckman-Coulter, Fullerton, CA) and stored at −70 °C.
Levels of IGF-1 were determined using an ELISA kit (Quantikine,
mouse IGF-1 immunoassay) according to manufacturer instructions
(R&D Systems, Minneapolis, MN).
2.6. Bone analysis of cytokines (tumor necrosis factor-alpha and
interleukin-6)
Expression of cytokines (TNF-α and IL-6) was detected by ELISA in
the supernatant of lysis buffer bones' extracts (RIPA buffer, Thermo
Scientiﬁc Inc., Waltham, MA). Bones were individually processed as
indicated for the mass spectrometric analysis and extracted with
120 μL of lysis buffer. ELISA analysis was performed according to
manufactured instructions (TNF-α: eBioscience, San Diego, CA; IL-6:
BD Biosciences, San Jose, CA) using 50 μL of bone's extract. Plates'
readings were performed in a Spectra Max 190 ELISA reader
(Molecular Devices, Sunnyvale, CA).
Table 1
Level of galactosylsphingosine (psychosine) in wild type and twitcher mice femora.
Femoraa
(pmol/g tissue)
Wild type 13±1
Twitcher 187±57⁎⁎
a Samples represent Mean±SD of psychosine concentrations found in femora from
wild type (n=3 sets) and twitcher (n=4 sets)mice, determined at postnatal days 32–33.
(Set includes the left and the right femur from each animal).
⁎⁎ : pb0.004.
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Liver total RNA was extracted using TRIzol (Invitrogen, Carlsbad,
CA) and the puriﬁed RNA used for the synthesis of cDNA. Single-
strand cDNA was synthesized from 2 µg of total RNA using iScript
cDNA Synthesis Kit (Bio-Rad Laboratories, Inc, Hercules, CA) accord-
ing to manufacturer's instructions. qPCR was conducted using iCycler
(iCycler iQ, Bio-Rad), speciﬁc primers for mouse IGF-1 (Cat. number
PPM03387E; SABiosciences, Frederick, MD) and iQ SYBR Green
Supermix (Bio-Rad). Thermal cycling conditions were as follows:
activation of DNA polymerase at 95 °C for 10 min, followed by 40
cycles of ampliﬁcation at 95 °C for 30 s and 60 °C for 30 s. The
expressions of target genes were normalized with respect to the
house keeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). All samples were run in duplicate. Statistical analysis was
performed by Student-t test (Graph Path InStat3, GraphPath Software
Inc., San Diego, CA) and the difference at pb0.05 was considered
statistically signiﬁcant.Fig. 2.Morphologic differences between the femur from wild type and twitcher mice. Light m
and twitcher (B, D) mouse bone identiﬁed differences in thickness of green-stained cortical
plate (GP) and reduction of green-stained trabecular bone (TB) (A, B: 40× magniﬁcation; l3. Results
3.1. Retarded growth of long bones (femora) of twitcher mouse and
galactosylsphingosine (psychosine) accumulation
Postnatal growth curves show that twi mouse body weight is
severely inhibited starting by day 20 (Fig. 1A), as reported by several
laboratories [34–36]. Taking long bones (femora) as representatives
of the animals' growth, we analyzed their physical differences
between wt and twi mice. The analysis of femora of wt and twi at
post natal days 32–33 indicated that twi bones have smaller size and
weighed 27% less than wt mice bones (Fig. 1B). Furthermore,
determination of psychosine levels by mass spectrometry indicated
that psychosine accumulates in twi bones of adults animals (33 days
old), at levels 14 fold higher than the levels found in wt (Table 1).3.2. Histomorphologic analysis of Twitcher femora
Examination of stained wt and twi femora under light micros-
copy revealed differences in cortical bone thickness, cellular
organization (isogenous groups) and width of the growth plate,
between wt and twi animals (Fig. 2A, B). The metaphyseal region of
twi bones also showed marked structural differences, with
reduction of trabecular bone (stained in green) mainly in the
region of the secondary spongiosa (Fig. 2C, D). Overall, there was a
marked decrease in cortical bone thickness and the number of
trabeculae, indicating the twi mouse shows an osteopenic
phenotype.icroscopic study of Goldner's trichrome stained sections derived from wild type (A, C)
bone (CB), organization and morphology of the chondrocytes and width of the growth
ine represents 2 mm; C, D: 60× magniﬁcation, line represents 200 μm).
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osteoclastic resorption) in femora of wild type and twitcher mice
To gain insight into the possible cause of reduced bone formation
in twi femora, the bone-forming capacity of osteoblasts was examined
by the deposition of calcein. The calcein labeling along the cortical
bone (seen as two layers of ﬂorescent green lines under the
ﬂuorescence microscopic analysis) showed no difference between
wt and twi (Fig. 3A, B), indicating no differences in the mineral
apposition rate. However, there was a substantial reduction of bone
deposition (green ﬂuorescence) in the metaphyseal and epiphyseal
region of twi femora (Fig. 3A, B). To evaluate whether enhanced
osteoclastic activity is the cause of the observed reduced calcein
deposition in both regions, we performed histochemical analysis for
tartrate-resistant acid phosphatase (TRAP) activity. TRAP-positive
osteoclasts were identiﬁed along the base of the growth plate and
most of the trabeculae and on the endosteal surface of the diaphysis in
both wt and twi mice bone showed activity (Fig. 3C, D). However,
TRAP staining was stronger in twi bone, and included the narrow
growth plate of the twi femur. These data indicate that psychosine-
induced alterations in twi bone preferentially affects the function of
osteoclasts and suggests that enhanced osteoclastic resorptionmay be
playing a role in the bone growth retardation observed in twi animals.
3.4. Sphingolipid homeostasis and cytokine markers in femora of
twitcher mouse
To evaluate possible changes in the osteoclast–osteoblast coupling
factor sphingosine-1-phosphate (Sph-1P) [37] and to better under-
stand the cause of reduced cellularity reported in twi bone marrowFig. 3. Bone deposition (osteoblasts activity) and resorption (osteoclasts activity) functions in
determined by double calcein labeling (green ﬂuorescence) during new bone formation/rem
the base of the growth plate as well as on most of the trabeculae (TB) and on the endoste
reduction of labeling in twitcher mouse trabeculae (trabecular bone, TB) (40×magniﬁcation
mice (D). TRAP assay was done as indicated in Material and methods (40× magniﬁcation).[36], we studied the levels of sphingolipid in femora. The analysis of
the wt and twi femora by mass spectrometry indicated a signiﬁcant
increase (1.3 fold) in the total sphingomyelin (SM) pool found in the
twi (341±10 nmol/g) when compared to wt bones (263±11 nmol/
g; pb0.0001) (Fig. 4A). The observed increase is mainly a contribution
of the saturated species C16:0-SM (1.3 fold), C18:0-SM (1.2 fold),
C20:0-SM(1.4 fold), C22:0-SM(1.4 fold), andC24:0-SM(1.2 fold); and
of the unsaturated species C22:1-SM (1.4 fold), C24:1-SM (1.4 fold)
and C26:1-SM (1.1 fold) (Table 2). On the other hand, the analysis of
the ceramide (CM) pool or Sph-1P did not indicate a signiﬁcant
difference betweenwt and twi bones (Fig. 4A, B). However, signiﬁcant
changes were observed in the individual saturated species C20:0-CM
(0.7 fold) and C22:0-CM (1.4 fold), DHC16:0 (0.8 fold), Sph (1.4 fold),
and the unsaturated species C24:1-CM (1.3 fold) (Table 3; Fig. 4B).
Interestingly, the most abundant species (C24:1) in SM as well as in
CM was signiﬁcantly elevated in both pools; and the dihydro-C16:0-
CM (DHC16:0; a de novo CM synthesis indicator [38]) was signiﬁcantly
decreased (Tables 2 and 3). Taking into account that the changes
observed in the total SM pool and SM species (including Sph)
represent an increase in concentrations in twi as compared with wt,
and minor variations in some CM saturated and unsaturated species,
these data suggest that psychosine accumulation in twi bones is
interfering with SM and CM turnover.
To rule out a possible psychosine-induced inﬂammatory process as
demonstrated in the brains and livers of twitcher mice [8,29], we
determined the bone's levels of the cytokines TNF-α and IL-6
(Table 4). Because the cytokines analysis did not indicate a signiﬁcant
difference between wild type and twitcher mice (Table 4), the results
suggest that psychosine is not exerting its effect by inducing the
expression of mediators of inﬂammation.the femora of twitcher mice. Osteoblasts function inwild type (A) and twitcher (B) was
odeling. Osteoclasts function (C, D), as TRAP-positive osteoclasts (red) can be seen along
al surface of the cortex in both wild type (C) and twitcher (D) mice. Note the drastic
; line represents 2 mm) (B) and the intense TRAP activity of the growth plate in twitcher
Fig. 4. Sphingolipids concentration in wild type and twitcher femora. The levels of
sphingomyelin (SM) and ceramide (CM) (A); sphingosine (Sph) and sphingosine-1-
phosphate (Sph-1P) (B) fractions were determined by HPLC-mass spectrometry in
organic extracts from femora of wild type (white bars) and twitcher mice (black bars),
as indicated in Materials and methods. Values in (A) were obtained from
the summation of the individual SM and CM fractions (including saturated and
unsaturated fatty acids fractions). Graph represent the average±SD for n=4 samples
per group. Asterisks denote signiﬁcant statistical differences from wild type littermates
(*: pb0.01; ***: pb0.0001).
Fig. 5. Insulin-like growth factor-1 levels in the plasma of twitcher mice. Plasma levels
of IGF-1 in wild type and twitcher mice were determined by ELISA assay at postnatal
day 33. Graph represents the average±SD for n=4 animals per group. Asterisks
denote signiﬁcant statistical differences from wild type littermates (**: pb0.002).
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expression and protein levels in liver
IGF-1 is a GH-dependent growth factor produced mainly by the
liver, and it is known to regulate growth and bone remodeling [39].
ELISA analysis of plasma levels of IGF-1 in wt and twi animals
indicated that IGF-1 levels were signiﬁcantly reduced by 37.6% in
twi animals as compared to wt (234.4±26.4 vs 148.7±20.5 ng/ml
in wt and twi respectively; pb0.002) (Fig. 5), and decreases as the
disease progresses (Fig. S1A, B). Because plasma circulating IGF-1 is
of hepatic origin and liver is also affected by psychosine-induced
disease in twi mice [29], we investigated the mRNA expression and
protein levels in liver of wt and twi mice. The hepatic expression of
IGF-1 mRNA was down regulated by 59.3% in adult animals (1.9±
0.4 in wt vs. 0.8±0.3 folds in twi; pb0.005) (Fig. 6A), whereas IGF-
1 protein levels were decreased by 60.4% (1.7±0.2 in wt vs. 0.7±
0.3 ng/mg of protein in twi; pb0.0001) (Fig. 6B) in twi liver as
compared with wt. This result indicated a strong alteration of the
liver functions in twi animals.4. Discussion
Twitchermouse is an animalmodel of the genetic disorder Globoid
cell leukodystrophy (Krabbe disease) [5,40,41]. These animals
develop clinical signs by day 20 (stunted growth, twitching, hind
leg weakness), and they reach a near-terminal stage by days 40–45
[1]. While the twitching sign is associated with oligodendrocytes
(myelin-forming cell) loss [16–18], the cause of twimouse decreased
growth is unclear. It is well established that psychosine accumulates
in nervous tissue [3], and exerts an inﬂammatory response charac-
terized by induction of proinﬂammatory cytokines, inducible nitric
oxide synthase, oxidative imbalance and early oligodendrocyte cell
death [8,11–15,42]. As the disease pathology progresses, the inﬂam-
matory process compromises further brain homeostasis, altering
subcellular functions of peroxisomes [42,43] and mitochondria
[44,45]. In parallel with the central nervous system events, psychosine
also accumulates in non-nervous tissues/organs, affecting their
homeostasis [29,36]. Our data demonstrated that psychosine also
accumulates in long bones (femora) of twitcher mice, where it may
exert cytotoxic effects, thus supporting the notion that globoid cell
leukodystrophy (Krabbe disease) is a generalized storage disease [4],
and adding another tissue to the list of those that accumulate
psychosine [29,36,46–48]. Such accumulation, however, does not
compare to the levels found in twi liver or brain (3 and 27 folds higher
than in bone, respectively) [29].
Many local [37,49–51], humoral/endocrine [20,21,26] and central
and peripheral nervous system-derived factors [39,52] regulate the
functions of the specialized cells such as osteoblasts (bone deposition)
and osteoclasts (bone resorption) responsible for bone growth/
remodeling [50]. Morphologic and functional analysis of wt and twi
femora demonstrated reduced content of cortical and trabecular bone
indicating that the twi mouse shows an osteopenic phenotype,
possibly a consequence of enhanced osteoclastic bone resorption
(TRAP activity) without much alteration of osteoblastic function
(calcein deposition). These data indicate that psychosine-induced
alterations in twi bone may uncouple bone deposition from bone
resorption. It affects preferentially osteoclastic function and suggests
that over time an enhanced osteoclastic resorption may be playing a
role in the premature closure of the growth plate; and hence is a
contributing factor to the reduction in bone growth in twi animals.
Interestingly, in another animal model of lysosomal disease, muco-
polyssacharidosis type VII (deﬁciency of the enzyme β-glucuroni-
dase), there is a metabolite-mediated bone alteration by impairment
of both osteoclastic and osteoblastic functions [53].
Table 2
Determination of the sphingomyelin fractions composition in wild type and twitcher femora.
Sphingomyelin fractionsa
(nmol/g tissue)
C14:0 C16:0 C18:0 C20:0 C22:0 C24:0 C26:0 C18:1 C20:1 C22:1 C24:1 C26:1
Wild type 1.07±0.05 110±4 39±3 4.7±0.5 14±2 36±2 0.35±0.05 2.9±0.3 0.36±0.07 2.6±0.4 52±5 0.75±0.04
Twitcher 1.23±0.17 143±6 48±2 6.5±0.6 19±2 42±3 0.33±0.05 3.2±0.3 0.44±0.06 3.6±0.4 73±4 0.85±0.05
pb ns 0.0001 0.001 0.001 0.002 0.005 ns ns ns 0.005 0.0002 0.01
a Individual sphingomyelin fractions were determined bymass spectrometry in deﬂeshed bone (wet weight) organic extracts. Values represent the average±SD for n=5 sets per
group. pb: Statistical signiﬁcance as indicated, versus wild type; ns: not signiﬁcant.
Table 3
Determination of the ceramide fractions composition in wild type and twitcher femora.
Ceramide fractionsa
(nmol/g tissue)
C14:0 C16:0 C18:0 C20:0 C22:0 C24:0 C26:0 C18:1 C20:1 C20:4 C22:1 C24:1 C26:1 DHC16:0
Wild type 6.2±3.4 32±8 10±2 10.4±2.1 7.5±0.8 33±4 0.13±0.04 4.2±0.3 2.8±0.4 0.07±0.02 3.7±0.5 38±5 0.36±0.06 22±3
Twitcher 5.0±2.2 34±4 10±1 7.5±1.1 10.3±0.5 35±5 0.11±0.06 3.7±0.6 2.3±0.4 0.04±0.01 4.0±0.4 51±4 0.32±0.07 18±1
pb ns ns ns 0.03 0.0002 ns ns ns ns ns ns 0.001 ns 0.03
a Individual ceramide fractions were determined by mass spectrometry in deﬂeshed bone (wet weight) organic extracts. Values represent the average±SD for n=5 sets per
group. pb: Statistical signiﬁcance as indicated, versus wild type; ns: not signiﬁcant.
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associated with activation of stress response/cell death [54], and Sph-
1P increase is associated with antiapoptotic/cell survival signals
[55,56]. In addition, in bone Sph-1P is a factor that regulates the
osteoclast–osteoblast coupling during bone growth/remodeling
[37,51]. In general, our sphingolipid analysis resembles the changes
reported for twi liver [29]; with insigniﬁcant changes in known
apoptotic (C16:0-CM) or antiapoptotic (Sph-1P) sphingolipid frac-
tions [38,57]. However, an increasewas found in total SM fraction, and
in most of the SM and CM containing saturated-unsaturated fatty
acids, including the most abundant species (C24:1) in SM and in CM.
On the other hand, the dehydro-C16:0 (DHC16:0; an indicator of de
novo CM synthesis [38]) was signiﬁcantly decreased and Sph
accumulated in twi mice. These data suggest that psychosine
accumulation may interfere with SM degradation and CM synthesis
in twi bones. Furthermore, the lipidomic analysis showing no
signiﬁcant changes on Sph-1P between wt and twi mice bone rules
out that this sphingolipid may be playing a role in the osteoclast–
osteoblast uncoupling [37]. These results suggest that the levels of
psychosine may not reach a threshold that is enough to trigger stress
response/cell death in twi bones. Consistent with these results,
analysis of the inﬂammationmarker TNF-α and IL-6were found not to
be altered, which strongly suggests that the psychosine-induced
pathology in twitcher bones is not dependent or potentiated by the
induction of mediators of inﬂammation, as demonstrated in the brain
and liver of those animals [8,29] or studies on cell culture [13]. On the
other hand, psychosine accumulation may be interfering with cell
signaling at the level of the receptor sites (lipids rafts), as suggestedTable 4
Level of cytokines (TNF-α and IL-6) in wild type and twitcher mice femora.
TNF-α IL-6
(pmol/g tissue)a
Wild type 86±56 152±79
Twitcher 112±76 149±63
a Samples represent Mean±SD of cytokines concentrations (tumor necrosis factor-
alpha, TNF-α; Interleukin-6, IL-6) found in femora from wild type (n=4 sets) and
twitcher (n=5 sets) mice, determined at postnatal days 33–35. (Set includes the left
and the right femur from each animal).recently [58]. Future studies should be aimed to identify the cellular
distribution of the accumulated psychosine in long bones.
Liver is the main organ that contributes to the blood circulating
IGF-1 pool [27,28,59]; with IGF-1 playing an important role in bone
physiology [25,60,61]. Taking into consideration that liver functions
are compromised by psychosine-induced inﬂammation in twi animals
[29], it was not surprising that mRNA expression and protein levels of
IGF-1 were found to be down regulated in the liver of twi mice,
supporting the drastic decrease in IGF-1 plasma levels observed in
those mice. These results indicate an additional psychosine-mediated
metabolic dysfunction in twi liver (synthesis of IGF-1), and suggest
that reduction in IGF-1 plasma levels may be an additional factor
contributing to the observed impaired balance (uncoupling) betweenFig. 6. Expression and protein level of insulin-like growth factor-1 in twitcher mice
liver. Wild type and twitcher mouse IGF-1 mRNA expression were determined by
quantitative PCR (A), and IGF-1 protein levels in liver homogenate soluble fractions
were determined by ELISA assay (B), as described in Materials and Methods. Graph
represents the average±SD for the number of animals indicated per group. Analysis
was performed in mice 33–34 days old. **: pb0.005 (n=3); ***: pb0.0001 (n=6).
Asterisks denote signiﬁcant statistical differences from wild type littermates. WT: wild
type mice; TW: Twitcher mice.
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stunting in twi mice. Studies performed in double gene disrupted
mice (liver IGF-1-deﬁcient and acid labile subunit (ALS) knockout)
support our results [62]; dramatic decrease in IGF-1 levels in both
animals is consistent with decreased bone growth. Indeed, the fewer
trabeculae in the metaphysis is a sign of osteopenia; and the smaller
growth plate in both cases is consistent with the narrowing of the
growth plate observed with aging, which is associated with decrease
in circulating and local production of IGF-1 [63–65]. Furthermore,
additional factors such as alteration of the hypothalamic–pituitary
axis in the nervous system [66], may also play a role in the
derangements of bone growth. Recent studies have reported drastic
changes in twi mice bone cellularity due to autonomic nerves
degeneration [36].
Our data and that of others demonstrate the complexity of the
development and progression of the psychosine-induced pathology in
the nervous system [11–13,36,43] and in peripheral organs [29,36],
and highlight the importance of peripheral organs for the overall
organism homeostasis [29]. Based on these observations, we
hypothesize that progression of inﬂammation in the twi central
nervous system could also affect hormones secretion which may play
a role in the homeostasis of peripheral organs, such as in bone growth
regulation [67,68].
In summary, we have identiﬁed two potential factors that may be
affecting bone growth in twi mice. We report that psychosine
accumulates in bones, where either maybe by itself as an endogenous
factor or in conjunction with a decrease of plasma IGF-1 levels,
preferentially impaired osteoclastic function, and hence stunted bone
growth. Therefore, recent therapeutic treatments [69,70] might
consider the supplementation/induction of endocrinous/paracrine
factors (i.e., GH-IGF-1). Combination therapy may prove to be of
beneﬁt for the central nervous system [71–73] and peripheral organs,
and ultimately for the amelioration of the development and
progression of the disease pathology in twimice and Krabbe patients.
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